These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 18023415)
1. Validation of HB-EGF and amphiregulin as targets for human cancer therapy. Yotsumoto F; Yagi H; Suzuki SO; Oki E; Tsujioka H; Hachisuga T; Sonoda K; Kawarabayashi T; Mekada E; Miyamoto S Biochem Biophys Res Commun; 2008 Jan; 365(3):555-61. PubMed ID: 18023415 [TBL] [Abstract][Full Text] [Related]
2. Epidermal growth factor receptor mediates stress-induced expression of its ligands in rat gastric epithelial cells. Miyazaki Y; Hiraoka S; Tsutsui S; Kitamura S; Shinomura Y; Matsuzawa Y Gastroenterology; 2001 Jan; 120(1):108-16. PubMed ID: 11208719 [TBL] [Abstract][Full Text] [Related]
3. Metalloproteinase-mediated, context-dependent function of amphiregulin and HB-EGF in human keratinocytes and skin. Stoll SW; Johnson JL; Bhasin A; Johnston A; Gudjonsson JE; Rittié L; Elder JT J Invest Dermatol; 2010 Jan; 130(1):295-304. PubMed ID: 19609315 [TBL] [Abstract][Full Text] [Related]
4. Histamine may induce airway remodeling through release of epidermal growth factor receptor ligands from bronchial epithelial cells. Hirota N; Risse PA; Novali M; McGovern T; Al-Alwan L; McCuaig S; Proud D; Hayden P; Hamid Q; Martin JG FASEB J; 2012 Apr; 26(4):1704-16. PubMed ID: 22247333 [TBL] [Abstract][Full Text] [Related]
5. Retinoid-induced epidermal hyperplasia is mediated by epidermal growth factor receptor activation via specific induction of its ligands heparin-binding EGF and amphiregulin in human skin in vivo. Rittié L; Varani J; Kang S; Voorhees JJ; Fisher GJ J Invest Dermatol; 2006 Apr; 126(4):732-9. PubMed ID: 16470170 [TBL] [Abstract][Full Text] [Related]
6. The EGFR ligands amphiregulin and heparin-binding egf-like growth factor promote peritoneal carcinomatosis in CXCR4-expressing gastric cancer. Yasumoto K; Yamada T; Kawashima A; Wang W; Li Q; Donev IS; Tacheuchi S; Mouri H; Yamashita K; Ohtsubo K; Yano S Clin Cancer Res; 2011 Jun; 17(11):3619-30. PubMed ID: 21482691 [TBL] [Abstract][Full Text] [Related]
7. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer. Tanaka Y; Miyamoto S; Suzuki SO; Oki E; Yagi H; Sonoda K; Yamazaki A; Mizushima H; Maehara Y; Mekada E; Nakano H Clin Cancer Res; 2005 Jul; 11(13):4783-92. PubMed ID: 16000575 [TBL] [Abstract][Full Text] [Related]
8. ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis. Révillion F; Lhotellier V; Hornez L; Bonneterre J; Peyrat JP Ann Oncol; 2008 Jan; 19(1):73-80. PubMed ID: 17962208 [TBL] [Abstract][Full Text] [Related]
9. Amphiregulin regulates the activation of ERK and Akt through epidermal growth factor receptor and HER3 signals involved in the progression of pancreatic cancer. Yotsumoto F; Fukami T; Yagi H; Funakoshi A; Yoshizato T; Kuroki M; Miyamoto S Cancer Sci; 2010 Nov; 101(11):2351-60. PubMed ID: 20726858 [TBL] [Abstract][Full Text] [Related]
10. Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells. Zhang X; Diaz MR; Yee D Breast Cancer Res Treat; 2013 Jun; 139(2):351-60. PubMed ID: 23686416 [TBL] [Abstract][Full Text] [Related]
12. Amphiregulin is coordinately expressed with heparin-binding epidermal growth factor-like growth factor in the interstitial smooth muscle of the human prostate. Adam RM; Borer JG; Williams J; Eastham JA; Loughlin KR; Freeman MR Endocrinology; 1999 Dec; 140(12):5866-75. PubMed ID: 10579352 [TBL] [Abstract][Full Text] [Related]
13. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4. Riese DJ; Kim ED; Elenius K; Buckley S; Klagsbrun M; Plowman GD; Stern DF J Biol Chem; 1996 Aug; 271(33):20047-52. PubMed ID: 8702723 [TBL] [Abstract][Full Text] [Related]
14. Evolution of the predictive markers amphiregulin and epiregulin mRNAs during long-term cetuximab treatment of KRAS wild-type tumor cells. Oliveras-Ferraros C; Massaguer Vall-Llovera A; Carrion Salip D; Vazquez-Martin A; Cufí S; Queralt B; Martin-Castillo B; Brunet J; de Llorens R; Menendez JA Invest New Drugs; 2012 Apr; 30(2):846-52. PubMed ID: 21161326 [TBL] [Abstract][Full Text] [Related]
15. Heparin-binding epidermal growth factor-like growth factor stimulates mitogenic signaling and is highly expressed in human malignant gliomas. Mishima K; Higashiyama S; Asai A; Yamaoka K; Nagashima Y; Taniguchi N; Kitanaka C; Kirino T; Kuchino Y Acta Neuropathol; 1998 Oct; 96(4):322-8. PubMed ID: 9796995 [TBL] [Abstract][Full Text] [Related]
16. Leptin stimulates the proliferation of human oesophageal adenocarcinoma cells via HB-EGF and Tgfalpha mediated transactivation of the epidermal growth factor receptor. Ogunwobi OO; Beales IL Br J Biomed Sci; 2008; 65(3):121-7. PubMed ID: 18986098 [TBL] [Abstract][Full Text] [Related]
17. The DNA damaging agent VP16 induces the expression of a subset of ligands from the EGF system in bladder cancer cells, whereas none of the four EGF receptors are induced. Sørensen BS; Tørring N; Bor MV; Nexø E Mol Cell Biochem; 2004 May; 260(1-2):129-35. PubMed ID: 15228094 [TBL] [Abstract][Full Text] [Related]
18. EGFR ligands drive multipotential stromal cells to produce multiple growth factors and cytokines via early growth response-1. Kerpedjieva SS; Kim DS; Barbeau DJ; Tamama K Stem Cells Dev; 2012 Sep; 21(13):2541-51. PubMed ID: 22316125 [TBL] [Abstract][Full Text] [Related]
19. Amphiregulin-EGFR signaling mediates the migration of bone marrow mesenchymal progenitors toward PTH-stimulated osteoblasts and osteocytes. Zhu J; Siclari VA; Liu F; Spatz JM; Chandra A; Divieti Pajevic P; Qin L PLoS One; 2012; 7(12):e50099. PubMed ID: 23300521 [TBL] [Abstract][Full Text] [Related]
20. Activation of epidermal growth factor receptor signaling by the prostaglandin E(2) receptor EP4 pathway during gastric tumorigenesis. Oshima H; Popivanova BK; Oguma K; Kong D; Ishikawa TO; Oshima M Cancer Sci; 2011 Apr; 102(4):713-9. PubMed ID: 21205091 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]